Latest Leadership News

Pinnacle Minerals Ltd has announced a $1.76 million capital raise through a two-tranche share placement with free attaching options, aiming to advance its exploration projects in Canada and Australia.

BluGlass Limited has secured its first order from the Indian Department of Defence and reported a significant 16% improvement in visible laser efficiency, alongside raising $7.6 million to support growth.

G11 Resources advances its Wilandra copper exploration with new geophysical surveys and strategic board appointments, while seeking NSW government co-funding for deeper drilling.

Adelong Gold Limited has achieved its first gold pour at the Challenger Gold Mine in NSW and completed a key drilling program at its Apollo Gold Project in Victoria, while acquiring the high-grade Lauriston Gold Project to bolster its exploration portfolio.

Thor Energy has reported significant progress in its natural hydrogen and helium exploration at the HY-Range Project, alongside strategic licence acquisitions and leadership changes. The company also signed a term sheet to sell a majority stake in its US uranium assets.

dorsaVi has acquired exclusive global rights to advanced RRAM technology, promising major performance gains in its biomedical sensors, while securing key contracts and raising $2.44 million to fuel US market growth.

Acrux Limited reports promising revenue growth driven by new topical generic launches in the US and secures crucial RDTI funding, marking a strategic shift under new CEO John Warmbrunn.

Solis Minerals has kicked off diamond drilling at its Chancho al Palo copper-gold project in Peru, revealing promising visual mineralisation including visible gold, while advancing permits and funding to support further exploration.

Future Metals NL has raised A$4.2 million and entered a strategic MOU with Zeta Resources to explore processing its Eileen Bore and Panton ores at the Savannah Mine plant, signalling a new phase of development amid rising PGM prices.

Actinogen Medical has reached a key milestone in its XanaMIA phase 2b/3 Alzheimer’s trial with over 100 participants enrolled, setting the stage for an interim analysis in January 2026. The company also secured a $13.8 million non-dilutive R&D funding facility to support ongoing development.

DroneShield Limited has reported record revenue growth in 2Q25, driven by soaring demand for AI-powered counterdrone solutions amid a global surge in defense spending. The company’s expanding $2.33 billion sales pipeline and strong cash position position it well for future growth.

Avecho Biotechnology has ramped up recruitment in its pivotal Phase III insomnia trial and is advancing plans for regulatory approval and commercialization of its TPM®-enhanced CBD capsule, aiming to be the first over-the-counter CBD insomnia treatment in Australia.